Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The PET-RPS Study: Utility of PET for Assessment of Response to Preoperative Chemotherapy in Primary Retroperitoneal Sarcoma (RPS)

NCT04224948 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT04224948
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04224948 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The PET-RPS Study: Utility of PET for Assessment of Response to Preoperative Chemotherapy in Primary Retroperitoneal Sarcoma (RPS)
Lead sponsor
University Health Network, Toronto
Phase
Not applicable
Overall status
Completed
Start date
January 3, 2020
Completion date
December 31, 2024
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

retroperitoneal sarcoma